speb/financial-data huggingface dataset:
CBI.V balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -143502.00
CBI.V balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1144418.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1144418.00
CBI.V cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 49739.00
CBI.V cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 32321.00
CBI.V cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 49739.00
CBI.V cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 32321.00
CBI.V income_statement (annual, 2025-12-31) — Basic Average Shares: 24333665.00
CBI.V income_statement (annual, 2025-12-31) — Basic EPS: -0.05
CBI.V cash_flow (annual, 2025-12-31) — Beginning Cash Position: 16346.00
CBI.V cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 6734.00
CBI.V balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 102450.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 102450.00
CBI.V cash_flow (annual, 2025-12-31) — Capital Expenditure: -220144.00
CBI.V cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -161020.00
CBI.V balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 121325.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 121325.00
CBI.V balance_sheet (annual, 2025-12-31) — Capital Stock: 18788230.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Capital Stock: 18788230.00
CBI.V balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 295061.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 295061.00
CBI.V balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 295061.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 295061.00
CBI.V cash_flow (annual, 2025-12-31) — Cash Dividends Paid: 0.00
CBI.V cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
CBI.V balance_sheet (annual, 2025-12-31) — Cash Financial: 295061.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Cash Financial: 295061.00
CBI.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 1306763.00
CBI.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 973957.00
CBI.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -180144.00
CBI.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -161020.00
CBI.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -855627.00
CBI.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -524447.00
CBI.V cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 379572.00
CBI.V cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 108142.00
CBI.V cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -124823.00
CBI.V cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -144884.00
CBI.V cash_flow (annual, 2025-12-31) — Change In Receivables: -97879.00
CBI.V cash_flow (quarterly, 2025-12-31) — Change In Receivables: -70000.00
CBI.V cash_flow (annual, 2025-12-31) — Change In Working Capital: 156870.00
CBI.V cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -106742.00
CBI.V cash_flow (annual, 2025-12-31) — Changes In Cash: 270991.00
CBI.V cash_flow (quarterly, 2025-12-31) — Changes In Cash: 288489.00
CBI.V balance_sheet (annual, 2025-12-31) — Common Stock: 18788230.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Common Stock: 18788230.00
CBI.V balance_sheet (annual, 2025-12-31) — Common Stock Equity: 3374912.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 3374912.00
CBI.V cash_flow (annual, 2025-12-31) — Common Stock Issuance: 1705098.00
CBI.V cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 1420198.00
CBI.V income_statement (annual, 2025-12-31) — Cost Of Revenue: 49739.00
CBI.V income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 32321.00
CBI.V balance_sheet (annual, 2025-12-31) — Current Assets: 619214.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Current Assets: 619214.00
CBI.V balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 44282.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 44282.00
CBI.V balance_sheet (annual, 2025-12-31) — Current Debt: 1033713.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Current Debt: 1033713.00
CBI.V balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1077995.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1077995.00
CBI.V balance_sheet (annual, 2025-12-31) — Current Liabilities: 1935732.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1935732.00
CBI.V cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 49739.00
CBI.V cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 32321.00
CBI.V cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 49739.00
CBI.V cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 32321.00
CBI.V income_statement (annual, 2025-12-31) — Diluted Average Shares: 24333665.00
CBI.V income_statement (annual, 2025-12-31) — Diluted EPS: -0.05
CBI.V income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -1226378.00
CBI.V income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -441011.00
CBI.V balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 112499.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 112499.00
CBI.V income_statement (annual, 2025-12-31) — EBIT: -1032136.00
CBI.V income_statement (quarterly, 2025-12-31) — EBIT: -430313.00
CBI.V income_statement (annual, 2025-12-31) — EBITDA: -982397.00
CBI.V income_statement (quarterly, 2025-12-31) — EBITDA: -397992.00
CBI.V cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 7724.00
CBI.V cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -162.00
CBI.V cash_flow (annual, 2025-12-31) — End Cash Position: 295061.00
CBI.V cash_flow (quarterly, 2025-12-31) — End Cash Position: 295061.00
CBI.V cash_flow (annual, 2025-12-31) — Financing Cash Flow: 1306763.00
CBI.V cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 973957.00
CBI.V cash_flow (annual, 2025-12-31) — Free Cash Flow: -1075771.00
CBI.V cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -685467.00
CBI.V cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 45144.00
CBI.V cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 0.00
CBI.V cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -3479.00
CBI.V cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 28.00
CBI.V income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 3479.00
CBI.V income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: -28.00
CBI.V income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 3948.00
CBI.V income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 17300.00
CBI.V balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 661663.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 661663.00
CBI.V income_statement (annual, 2025-12-31) — General And Administrative Expense: 843123.00
CBI.V income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 268873.00
CBI.V balance_sheet (annual, 2025-12-31) — Gross PPE: 4911975.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Gross PPE: 4911975.00
CBI.V income_statement (annual, 2025-12-31) — Gross Profit: -49739.00
CBI.V income_statement (quarterly, 2025-12-31) — Gross Profit: -32321.00
CBI.V income_statement (annual, 2025-12-31) — Interest Expense: 194242.00
CBI.V income_statement (quarterly, 2025-12-31) — Interest Expense: 10698.00
CBI.V income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 194242.00
CBI.V income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 10698.00
CBI.V cash_flow (annual, 2025-12-31) — Interest Paid Cff: -16910.00
CBI.V cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: 37381.00
CBI.V balance_sheet (annual, 2025-12-31) — Invested Capital: 4408625.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Invested Capital: 4408625.00
CBI.V cash_flow (annual, 2025-12-31) — Investing Cash Flow: -180144.00
CBI.V cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -161020.00
CBI.V balance_sheet (annual, 2025-12-31) — Investments And Advances: 0.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 0.00
CBI.V cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 1705098.00
CBI.V cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 1420198.00
CBI.V cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
CBI.V balance_sheet (annual, 2025-12-31) — Land And Improvements: 97827.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 97827.00
CBI.V balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 77043.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 77043.00
CBI.V balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 77043.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 77043.00
CBI.V cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
CBI.V cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -326598.00
CBI.V cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -311208.00
CBI.V balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 105439.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 105439.00
CBI.V cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 1705098.00
CBI.V cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 1420198.00
CBI.V balance_sheet (annual, 2025-12-31) — Net Debt: 738652.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Net Debt: 738652.00
CBI.V cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -51976.00
CBI.V cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -16438.00
CBI.V income_statement (annual, 2025-12-31) — Net Income: -1226378.00
CBI.V income_statement (quarterly, 2025-12-31) — Net Income: -441011.00
CBI.V income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -1226378.00
CBI.V income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -441011.00
CBI.V income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -1226378.00
CBI.V income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -441011.00
CBI.V income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -1226378.00
CBI.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -441011.00
CBI.V income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -1226378.00
CBI.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -441011.00
CBI.V cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -1226378.00
CBI.V cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -441011.00
CBI.V income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -1226378.00
CBI.V income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -441011.00
CBI.V income_statement (annual, 2025-12-31) — Net Interest Income: -194242.00
CBI.V income_statement (quarterly, 2025-12-31) — Net Interest Income: -10698.00
CBI.V cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 40000.00
CBI.V cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 0.00
CBI.V cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -326598.00
CBI.V cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -311208.00
CBI.V cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -326598.00
CBI.V cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -311208.00
CBI.V income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -194242.00
CBI.V income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -10698.00
CBI.V cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -54827.00
CBI.V cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -172414.00
CBI.V balance_sheet (annual, 2025-12-31) — Net PPE: 4768473.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Net PPE: 4768473.00
CBI.V cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -220144.00
CBI.V cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -161020.00
CBI.V balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 3374912.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 3374912.00
CBI.V income_statement (annual, 2025-12-31) — Normalized EBITDA: -989824.00
CBI.V income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -415264.00
CBI.V income_statement (annual, 2025-12-31) — Normalized Income: -1233805.00
CBI.V income_statement (quarterly, 2025-12-31) — Normalized Income: -458283.00
CBI.V cash_flow (annual, 2025-12-31) — Operating Cash Flow: -855627.00
CBI.V cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -524447.00
CBI.V cash_flow (annual, 2025-12-31) — Operating Gains Losses: -10311.00
CBI.V cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -16410.00
CBI.V income_statement (annual, 2025-12-31) — Operating Income: -1120842.00
CBI.V income_statement (quarterly, 2025-12-31) — Operating Income: -470272.00
CBI.V income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
CBI.V income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
CBI.V balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 33028200.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 33028200.00
CBI.V balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 1033713.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 1033713.00
CBI.V balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 661663.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 661663.00
CBI.V balance_sheet (annual, 2025-12-31) — Other Equity Interest: 847016.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 847016.00
CBI.V income_statement (annual, 2025-12-31) — Other Gand A: 671828.00
CBI.V income_statement (quarterly, 2025-12-31) — Other Gand A: 222906.00
CBI.V income_statement (annual, 2025-12-31) — Other Income Expense: 88706.00
CBI.V income_statement (quarterly, 2025-12-31) — Other Income Expense: 39959.00
CBI.V cash_flow (annual, 2025-12-31) — Other Non Cash Items: 168874.00
CBI.V cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 7395.00
CBI.V income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 81279.00
CBI.V income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 22687.00
CBI.V income_statement (annual, 2025-12-31) — Other Operating Expenses: 26855.00
CBI.V balance_sheet (annual, 2025-12-31) — Other Properties: 4606259.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Other Properties: 4606259.00
CBI.V balance_sheet (annual, 2025-12-31) — Other Receivables: 129940.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Other Receivables: 129940.00
CBI.V balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 0.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 0.00
CBI.V balance_sheet (annual, 2025-12-31) — Payables: 857737.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Payables: 857737.00
CBI.V balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 857737.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 857737.00
CBI.V balance_sheet (annual, 2025-12-31) — Prepaid Assets: 156146.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 156146.00
CBI.V income_statement (annual, 2025-12-31) — Pretax Income: -1226378.00
CBI.V income_statement (quarterly, 2025-12-31) — Pretax Income: -441011.00
CBI.V cash_flow (annual, 2025-12-31) — Purchase Of PPE: -220144.00
CBI.V cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -161020.00
CBI.V balance_sheet (annual, 2025-12-31) — Receivables: 168007.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Receivables: 168007.00
CBI.V income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 49739.00
CBI.V income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 32321.00
CBI.V income_statement (annual, 2025-12-31) — Reconciled Depreciation: 49739.00
CBI.V income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 32321.00
CBI.V cash_flow (annual, 2025-12-31) — Repayment Of Debt: -326598.00
CBI.V cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -311208.00
CBI.V balance_sheet (annual, 2025-12-31) — Retained Earnings: -18066415.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -18066415.00
CBI.V income_statement (annual, 2025-12-31) — Salaries And Wages: 171295.00
CBI.V income_statement (quarterly, 2025-12-31) — Salaries And Wages: 45967.00
CBI.V cash_flow (annual, 2025-12-31) — Sale Of Investment: 40000.00
CBI.V cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 0.00
CBI.V cash_flow (annual, 2025-12-31) — Sale Of PPE: 0.00
CBI.V cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 0.00
CBI.V income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 197589.00
CBI.V income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 142171.00
CBI.V income_statement (annual, 2025-12-31) — Selling General And Administration: 1040712.00
CBI.V income_statement (quarterly, 2025-12-31) — Selling General And Administration: 411044.00
CBI.V balance_sheet (annual, 2025-12-31) — Share Issued: 33028200.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Share Issued: 33028200.00
CBI.V income_statement (annual, 2025-12-31) — Special Income Charges: 3479.00
CBI.V income_statement (quarterly, 2025-12-31) — Special Income Charges: -28.00
CBI.V cash_flow (annual, 2025-12-31) — Stock Based Compensation: 1579.00
CBI.V cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 0.00
CBI.V balance_sheet (annual, 2025-12-31) — Stockholders Equity: 3374912.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 3374912.00
CBI.V balance_sheet (annual, 2025-12-31) — Tangible Book Value: 3374912.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 3374912.00
CBI.V income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CBI.V income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CBI.V income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
CBI.V income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
CBI.V balance_sheet (annual, 2025-12-31) — Taxes Receivable: 38067.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 38067.00
CBI.V balance_sheet (annual, 2025-12-31) — Total Assets: 5387687.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Total Assets: 5387687.00
CBI.V balance_sheet (annual, 2025-12-31) — Total Capitalization: 3374912.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 3374912.00
CBI.V balance_sheet (annual, 2025-12-31) — Total Debt: 1155038.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Total Debt: 1155038.00
CBI.V balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 3374912.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 3374912.00
CBI.V income_statement (annual, 2025-12-31) — Total Expenses: 1120842.00
CBI.V income_statement (quarterly, 2025-12-31) — Total Expenses: 470272.00
CBI.V balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 2012775.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 2012775.00
CBI.V balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 4768473.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 4768473.00
CBI.V balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 77043.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 77043.00
CBI.V income_statement (annual, 2025-12-31) — Total Unusual Items: 7427.00
CBI.V income_statement (quarterly, 2025-12-31) — Total Unusual Items: 17272.00
CBI.V income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 7427.00
CBI.V income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 17272.00
CBI.V cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 4000.00
CBI.V cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
CBI.V balance_sheet (annual, 2025-12-31) — Working Capital: -1316518.00
CBI.V balance_sheet (quarterly, 2025-12-31) — Working Capital: -1316518.00
CBIO balance_sheet (annual, 2024-12-31) — Accounts Payable: 107000.00
CBIO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 0.00
CBIO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 2387000.00
CBIO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 0.00
CBIO balance_sheet (annual, 2024-12-31) — Capital Stock: 1000.00
CBIO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 34766000.00
CBIO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 34766000.00
CBIO balance_sheet (annual, 2024-12-31) — Cash Financial: 34766000.00
CBIO cash_flow (quarterly, 2024-12-31) — Change In Receivables: 0.00
CBIO cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: 0.00
CBIO balance_sheet (annual, 2024-12-31) — Common Stock: 1000.00
CBIO balance_sheet (annual, 2024-12-31) — Common Stock Equity: -15479000.00
CBIO cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 315000.00
CBIO cash_flow (quarterly, 2024-12-31) — Common Stock Payments: 0.00
CBIO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 2210000.00
CBIO balance_sheet (annual, 2024-12-31) — Current Assets: 34804000.00
CBIO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 0.00
CBIO balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 0.00
CBIO balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 0.00
CBIO balance_sheet (annual, 2024-12-31) — Current Liabilities: 9614000.00
CBIO balance_sheet (annual, 2024-12-31) — Dueto Related Parties Current: 7221000.00
CBIO cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: 1000000.00
CBIO balance_sheet (annual, 2024-12-31) — Gross PPE: 0.00
CBIO balance_sheet (annual, 2024-12-31) — Interest Payable: 852000.00
CBIO balance_sheet (annual, 2024-12-31) — Invested Capital: 22003000.00
CBIO cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 4315000.00
CBIO cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 37480000.00
CBIO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 0.00
CBIO balance_sheet (annual, 2024-12-31) — Long Term Debt: 37482000.00
CBIO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 37482000.00
CBIO cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 37480000.00
CBIO cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 315000.00
CBIO balance_sheet (annual, 2024-12-31) — Net Debt: 2716000.00
CBIO cash_flow (quarterly, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
CBIO cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 37480000.00
CBIO cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: 37480000.00
CBIO balance_sheet (annual, 2024-12-31) — Net PPE: 0.00
CBIO cash_flow (quarterly, 2024-12-31) — Net Preferred Stock Issuance: 4000000.00
CBIO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -15479000.00
CBIO balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 813000.00
CBIO cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 1000000.00
CBIO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 19500000.00
CBIO balance_sheet (annual, 2024-12-31) — Other Current Assets: 38000.00
CBIO balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 61000.00
CBIO balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 813000.00
CBIO balance_sheet (annual, 2024-12-31) — Payables: 7328000.00
CBIO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 9538000.00
CBIO balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 15000.00
CBIO balance_sheet (annual, 2024-12-31) — Preferred Securities Outside Stock Equity: 4000000.00
CBIO balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CBIO cash_flow (quarterly, 2024-12-31) — Preferred Stock Issuance: 4000000.00
CBIO balance_sheet (annual, 2024-12-31) — Prepaid Assets: 0.00
CBIO cash_flow (quarterly, 2024-12-31) — Purchase Of Intangibles: 0.00
CBIO balance_sheet (annual, 2024-12-31) — Receivables: 0.00
CBIO cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: 0.00
CBIO balance_sheet (annual, 2024-12-31) — Retained Earnings: -17867000.00
CBIO income_statement (quarterly, 2024-12-31) — Salaries And Wages: 1153000.00
CBIO balance_sheet (annual, 2024-12-31) — Share Issued: 19500000.00
CBIO balance_sheet (annual, 2024-12-31) — Stockholders Equity: -15479000.00
CBIO balance_sheet (annual, 2024-12-31) — Tangible Book Value: -15479000.00
CBIO income_statement (quarterly, 2024-12-31) — Tax Provision: 0.00
CBIO balance_sheet (annual, 2024-12-31) — Total Assets: 35617000.00
CBIO balance_sheet (annual, 2024-12-31) — Total Capitalization: 22003000.00
CBIO balance_sheet (annual, 2024-12-31) — Total Debt: 37482000.00
CBIO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -15479000.00
CBIO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 51096000.00
CBIO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 813000.00
CBIO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 41482000.00
CBIO balance_sheet (annual, 2024-12-31) — Total Tax Payable: 0.00
CBIO balance_sheet (annual, 2024-12-31) — Working Capital: 25190000.00
CBIO income_statement (quarterly, 2025-03-31) — +Operating Expense: 14224000.00
CBIO income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
CBIO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 19500000.00
CBIO income_statement (quarterly, 2025-03-31) — Basic EPS: -0.78
CBIO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 34766000.00
CBIO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -1486000.00
CBIO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 0.00
CBIO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -10851000.00
CBIO cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 518000.00
CBIO cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 1759000.00
CBIO cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 0.00
CBIO cash_flow (quarterly, 2025-03-31) — Change In Payable: 1678000.00
CBIO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 3437000.00
CBIO cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -371000.00
CBIO cash_flow (quarterly, 2025-03-31) — Change In Receivables: 0.00
CBIO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 3066000.00
CBIO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 0.00
CBIO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -12337000.00
CBIO cash_flow (quarterly, 2025-03-31) — Depreciation: 0.00
CBIO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 0.00
CBIO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 0.00
CBIO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 19500000.00
CBIO income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.78
CBIO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -15148000.00
CBIO income_statement (quarterly, 2025-03-31) — EBIT: -14036000.00
CBIO income_statement (quarterly, 2025-03-31) — EBITDA: -14036000.00
CBIO cash_flow (quarterly, 2025-03-31) — End Cash Position: 22429000.00
CBIO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -1486000.00
CBIO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -10851000.00
CBIO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 3597000.00
CBIO income_statement (quarterly, 2025-03-31) — Interest Expense: 1112000.00
CBIO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 1112000.00
CBIO income_statement (quarterly, 2025-03-31) — Interest Income: 188000.00
CBIO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 188000.00
CBIO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 0.00
CBIO income_statement (quarterly, 2025-03-31) — Net Income: -15148000.00
CBIO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -15148000.00
CBIO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -15148000.00
CBIO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -15148000.00
CBIO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -15148000.00
CBIO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -15148000.00
CBIO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -15148000.00
CBIO cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: 0.00
CBIO income_statement (quarterly, 2025-03-31) — Net Interest Income: -924000.00
CBIO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -924000.00
CBIO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -1491000.00
CBIO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 0.00
CBIO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -14036000.00
CBIO income_statement (quarterly, 2025-03-31) — Normalized Income: -15148000.00
CBIO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -10851000.00
CBIO income_statement (quarterly, 2025-03-31) — Operating Income: -14224000.00
CBIO income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
CBIO income_statement (quarterly, 2025-03-31) — Other Gand A: 1937000.00
CBIO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 2000.00
CBIO income_statement (quarterly, 2025-03-31) — Pretax Income: -15148000.00
CBIO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 5000.00
CBIO cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: 0.00
CBIO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: 0.00
CBIO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 0.00
CBIO income_statement (quarterly, 2025-03-31) — Research And Development: 10627000.00
CBIO income_statement (quarterly, 2025-03-31) — Salaries And Wages: 1660000.00
CBIO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 3597000.00
CBIO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 1229000.00
CBIO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CBIO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
CBIO income_statement (quarterly, 2025-03-31) — Total Expenses: 14224000.00
CBIO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -14224000.00
CBIO income_statement (quarterly, 2025-06-30) — +Operating Expense: 21030000.00
CBIO income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
CBIO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1648000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 190045000.00
CBIO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 3856925.00
CBIO income_statement (quarterly, 2025-06-30) — Basic EPS: -4.93
CBIO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 22429000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 1644000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 4014000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 152645000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 152645000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Cash Financial: 152645000.00
CBIO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 146864000.00
CBIO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -140000.00
CBIO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -16402000.00
CBIO cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -949000.00
CBIO cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 2658000.00
CBIO cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 14000.00
CBIO cash_flow (quarterly, 2025-06-30) — Change In Payable: -4147000.00
CBIO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -1489000.00
CBIO cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -763000.00
CBIO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -2160000.00
CBIO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 130322000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Common Stock: 14000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 135254000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 6042000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Current Assets: 154227000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 211000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 211000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 16746000.00
CBIO cash_flow (quarterly, 2025-06-30) — Depreciation: 2000.00
CBIO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 2000.00
CBIO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 2000.00
CBIO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 3856925.00
CBIO income_statement (quarterly, 2025-06-30) — Diluted EPS: -4.93
CBIO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -21790000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 5183000.00
CBIO income_statement (quarterly, 2025-06-30) — EBIT: -20717000.00
CBIO income_statement (quarterly, 2025-06-30) — EBITDA: -20715000.00
CBIO cash_flow (quarterly, 2025-06-30) — End Cash Position: 152751000.00
CBIO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 146864000.00
CBIO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -16542000.00
CBIO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 8949000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 1800000.00
CBIO income_statement (quarterly, 2025-06-30) — Interest Expense: 1073000.00
CBIO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 1073000.00
CBIO income_statement (quarterly, 2025-06-30) — Interest Income: 313000.00
CBIO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 313000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Interest Payable: 0.00
CBIO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 135254000.00
CBIO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -140000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 1433000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 1433000.00
CBIO income_statement (quarterly, 2025-06-30) — Net Income: -21790000.00
CBIO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -21790000.00
CBIO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -21790000.00
CBIO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -21790000.00
CBIO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -21790000.00
CBIO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -21790000.00
CBIO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -21790000.00
CBIO income_statement (quarterly, 2025-06-30) — Net Interest Income: -760000.00
CBIO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -760000.00
CBIO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 2760000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Net PPE: 1800000.00
CBIO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -140000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 139254000.00
CBIO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -20715000.00
CBIO income_statement (quarterly, 2025-06-30) — Normalized Income: -21790000.00
CBIO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -16402000.00
CBIO income_statement (quarterly, 2025-06-30) — Operating Income: -21030000.00
CBIO income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
CBIO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 16782562.00
CBIO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 1582000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 2096000.00
CBIO income_statement (quarterly, 2025-06-30) — Other Gand A: 8949000.00
CBIO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 2206000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 1406000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Other Properties: 1800000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Payables: 6831000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 12873000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 1566000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Preferred Securities Outside Stock Equity: 0.00
CBIO balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 4000000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 4000000.00
CBIO income_statement (quarterly, 2025-06-30) — Pretax Income: -21790000.00
CBIO cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
CBIO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -140000.00
CBIO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 2000.00
CBIO income_statement (quarterly, 2025-06-30) — Research And Development: 12081000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -54805000.00
CBIO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 8949000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Share Issued: 16782562.00
CBIO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 5340000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 139254000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 135254000.00
CBIO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CBIO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
CBIO balance_sheet (quarterly, 2025-06-30) — Total Assets: 157433000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 139254000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Total Debt: 1644000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 139254000.00
CBIO income_statement (quarterly, 2025-06-30) — Total Expenses: 21030000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 18179000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 3206000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 1433000.00
CBIO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -21030000.00
CBIO balance_sheet (quarterly, 2025-06-30) — Working Capital: 137481000.00
CBIO income_statement (quarterly, 2025-09-30) — +Operating Expense: 25885000.00
CBIO income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
CBIO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 2561000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 192039000.00
CBIO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 16540771.00
CBIO income_statement (quarterly, 2025-09-30) — Basic EPS: -1.27
CBIO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 152751000.00
CBIO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -586000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 1741000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 4014000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 133265000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 133265000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Cash Financial: 133265000.00
CBIO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -1254000.00
CBIO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -586000.00
CBIO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -17539000.00
CBIO cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 1488000.00
CBIO cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 2005000.00
CBIO cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 46000.00
CBIO cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 47000.00
CBIO cash_flow (quarterly, 2025-09-30) — Change In Payable: 2578000.00
CBIO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 4583000.00
CBIO cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 284000.00
CBIO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 4960000.00
CBIO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -19379000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Common Stock: 14000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 112641000.00
CBIO cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: -1254000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 6214000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Current Assets: 134563000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 417000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 417000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 20304000.00
CBIO cash_flow (quarterly, 2025-09-30) — Depreciation: 28000.00
CBIO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 28000.00
CBIO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 28000.00
CBIO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 16540771.00
CBIO income_statement (quarterly, 2025-09-30) — Diluted EPS: -1.27
CBIO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -24607000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 6273000.00
CBIO income_statement (quarterly, 2025-09-30) — EBIT: -24607000.00
CBIO income_statement (quarterly, 2025-09-30) — EBITDA: -24579000.00
CBIO cash_flow (quarterly, 2025-09-30) — End Cash Position: 133372000.00
CBIO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -1254000.00
CBIO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -18125000.00
CBIO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 5538000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 2346000.00
CBIO income_statement (quarterly, 2025-09-30) — Interest Expense: 0.00
CBIO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 0.00
CBIO income_statement (quarterly, 2025-09-30) — Interest Income: 1278000.00
CBIO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 1278000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Interest Payable: 0.00
CBIO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 112641000.00
CBIO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -586000.00
CBIO cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: -1254000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 1324000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1324000.00
CBIO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -1077000.00
CBIO income_statement (quarterly, 2025-09-30) — Net Income: -24607000.00
CBIO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -24607000.00
CBIO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -24607000.00
CBIO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -24607000.00
CBIO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -24607000.00
CBIO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -24607000.00
CBIO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -24607000.00
CBIO income_statement (quarterly, 2025-09-30) — Net Interest Income: 1278000.00
CBIO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 1278000.00
CBIO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 0.00
CBIO balance_sheet (quarterly, 2025-09-30) — Net PPE: 2346000.00
CBIO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -586000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 116641000.00
CBIO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -24579000.00
CBIO income_statement (quarterly, 2025-09-30) — Normalized Income: -24607000.00
CBIO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -17539000.00
CBIO income_statement (quarterly, 2025-09-30) — Operating Income: -25885000.00
CBIO income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
CBIO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 16782516.00
CBIO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1298000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 2088000.00
CBIO income_statement (quarterly, 2025-09-30) — Other Gand A: 2313000.00
CBIO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 94000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 1360000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Other Properties: 2346000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Payables: 8834000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 15048000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 2751000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Preferred Securities Outside Stock Equity: 0.00
CBIO balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 4000000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 4000000.00
CBIO income_statement (quarterly, 2025-09-30) — Pretax Income: -24607000.00
CBIO cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: -177000.00
CBIO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -586000.00
CBIO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 28000.00
CBIO income_statement (quarterly, 2025-09-30) — Research And Development: 20347000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -79412000.00
CBIO income_statement (quarterly, 2025-09-30) — Salaries And Wages: 3225000.00
CBIO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 5538000.00
CBIO balance_sheet (quarterly, 2025-09-30) — Share Issued: 16782516.00
CBIO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 1986000.00